We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Report Analyzes Trends in Laboratory Automation

By LabMedica International staff writers
Posted on 12 Mar 2013
The reduction of government reimbursement rates for laboratory tests and managed care cost-restraint measures has increased pressures for clinical labs to become more productive and cost efficient, according to a recent market report. More...
This is a key driver of the USD 10.4-billion-dollar lab automation sector, which includes systems for clinical and drug discovery labs.

However, the need to increase efficiency is hampered by the decreasing number of trained laboratory technologists and the expanding menu of diagnostic testing protocols. Frequently, increased efficiency means increasing or maintaining the timely output of test results with the same number or fewer technologists.

The report, published by healthcare market research publisher Kalorama Information (New York, NY, USA), explained that labs are not totally automating. When the trend toward clinical laboratory automation first began, in the early to mid-1990s, it was expected to include all lab functions—total laboratory automation (TLA). Targeted to the largest high volume laboratories, TLA requires a major financial commitment—in the millions—and the space for installing equipment. TLA is neither an affordable nor a practical solution for the majority of small to midsized hospital and other diagnostic laboratories. More recently, the trend for most clinical labs, and for many automation system manufacturers, has been toward modular automation, which includes independent work cells or self-contained workstations, and automation for transport, handling, and pre- and postanalytic processes.

In the US, only about 7% of the laboratories are considered able to benefit from TLA. A 500-bed hospital or smaller, for instance, is not suitable for TLA, unless it has a large outpatient business. A typical midsize to large lab in the US processes up to 3,000 tests per day. But with an aging population and the evolution of personalized medicine and molecular diagnostics, more labs are considering going total, according to the report.

“The best place to automate is at a lab’s preanalytical front end,” said Joe Constance, Kalorama Information analyst and author of the report, “minimizing those non-value-added steps, including such processes as sorting tubes, decapping, centrifugation, loading analyzers. Only a small number of labs are considered suitable for total automation, though each year that number gets larger. Usually, experts believe a laboratory should be performing at least one million to two million tests annually before installing a total system.”

According to Kalorama, labor accounts for more than 60% of the cost of producing test results. Automating a lab increases the available time for value-added steps, the tasks that technologists perform that help make a difference in the quality of the test, such as reviewing critical results.

Kalorama Information supplies independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices, and healthcare.

Related Links:
Kalorama Information



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.